Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma.

Ayada, Ibrahim; Li, Jiajing; Brouwer, Willem Pieter; de Knegt, Robert J; Pan, Qiuwei

Ayada, Ibrahim; Li, Jiajing; Brouwer, Willem Pieter; de Knegt, Robert J; Pan, Qiuwei.

Affiliation

Ayada I; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. i.ayada@erasmusmc.nl.
Li J; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Pan Q; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Hepatol Int ; 18(3): 1053-1055, 2024 Jun.

Article de En | MEDLINE | ID: mdl-38451406

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome hépatocellulaire / Hépatite B chronique / Tumeurs du foie Limites: Humans Langue: En Journal: Hepatol Int / Hepatol. int. (Internet) / Hepatology international (Internet) Année: 2024 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google